Frovatriptan
CAS 158747-02-5
In Stock
Frovatriptan
Cat. No. STUB-API-FROVATRIPTANCAS 158747-02-5In Stock
Technical Data
Cat. No.STUB-API-FROVATRIPTAN
CAS158747-02-5
Mol. FormulaC14H17N3O
Mol. Weight243.31 g/mol
IUPAC(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide
SMILESCN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
InChIInChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1
InChI KeyXPSQPHWEGNHMSK-SECBINFHSA-N
Purity—
Description
Overview
Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation
Anant Labs manufacture and furnish high quality Frovatriptan impurities for global markets. Our Frovatriptan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Frovatriptan158747-02-5MiguardAllergo filmtablettenSB 209509(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamideH82Q2D5WA7DTXSID00230801H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboximidic acid
